- Home
- PRAX vs ULCC Comparison
PRAX vs ULCC Comparison
Compare PRAX & ULCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- ULCC
- Stock Information
- Founded
- PRAX 2015
- ULCC 1994
- Country
- PRAX United States
- ULCC United States
- Employees
- PRAX N/A
- ULCC N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- ULCC Air Freight/Delivery Services
- Sector
- PRAX Health Care
- ULCC Consumer Discretionary
- Exchange
- PRAX Nasdaq
- ULCC Nasdaq
- Market Cap
- PRAX 1.5B
- ULCC 1.5B
- IPO Year
- PRAX 2020
- ULCC 2021
- Fundamental
- Price
- PRAX $71.55
- ULCC $6.39
- Analyst Decision
- PRAX Strong Buy
- ULCC Hold
- Analyst Count
- PRAX 9
- ULCC 11
- Target Price
- PRAX $146.33
- ULCC $6.68
- AVG Volume (30 Days)
- PRAX 315.5K
- ULCC 2.7M
- Earning Date
- PRAX 11-06-2024
- ULCC 02-04-2025
- Dividend Yield
- PRAX N/A
- ULCC N/A
- EPS Growth
- PRAX N/A
- ULCC N/A
- EPS
- PRAX N/A
- ULCC N/A
- Revenue
- PRAX $1,605,000.00
- ULCC $3,664,000,000.00
- Revenue This Year
- PRAX N/A
- ULCC $6.21
- Revenue Next Year
- PRAX N/A
- ULCC $14.27
- P/E Ratio
- PRAX N/A
- ULCC N/A
- Revenue Growth
- PRAX N/A
- ULCC 1.66
- 52 Week Low
- PRAX $16.08
- ULCC $2.79
- 52 Week High
- PRAX $86.93
- ULCC $8.33
- Technical
- Relative Strength Index (RSI)
- PRAX 50.90
- ULCC 57.13
- Support Level
- PRAX $70.03
- ULCC $6.16
- Resistance Level
- PRAX $73.49
- ULCC $7.07
- Average True Range (ATR)
- PRAX 4.10
- ULCC 0.40
- MACD
- PRAX -0.17
- ULCC 0.07
- Stochastic Oscillator
- PRAX 48.89
- ULCC 62.68
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.
About ULCC Frontier Group Holdings Inc.
Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers.